Form 8-K - Current report:
SEC Accession No. 0001437749-26-020154
Filing Date
2026-06-10
Accepted
2026-06-10 16:05:18
Documents
12
Period of Report
2026-06-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K iccc20260608_8k.htm   iXBRL 8-K 34074
  Complete submission text file 0001437749-26-020154.txt   164842

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iccc-20260604.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20260604_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20260604_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20260604_pre.xml EX-101.PRE 11584
15 EXTRACTED XBRL INSTANCE DOCUMENT iccc20260608_8k_htm.xml XML 2832
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 261079642
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)